InvestorsHub Logo
Followers 18
Posts 1458
Boards Moderated 0
Alias Born 11/01/2018

Re: None

Sunday, 04/11/2021 12:21:27 PM

Sunday, April 11, 2021 12:21:27 PM

Post# of 461946
Company website posted on December 15th 2020.

Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome.

https://www.anavex.com/anavex-life-sciences-announces-anavex2-73-blarcamesine-meets-primary-and-secondary-endpoints-in-placebo-controlled-u-s-phase-2-clinical-trial-for-the-treatment-of-adult-patients-with-rett-syn/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News